| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |